This presentation will discuss the current recommendations regarding preoperative management of GLP-RAs and the utility of gastric ultrasound in preventing the risk of pulmonary aspiration in patients taking these medications. GLP-1RAs are proving to be very effective medications for diabetic management as well as generalized weight loss which has increased its utilization in the diabetic and obese patient populations. Despite numerous benefits that these medications offer, significant gastrointestinal side effects have been noted including gastroparesis. There is consensus in the literature that patients taking GLP-1RAs who have followed current fasting guidelines are presenting to the operating room with full stomachs increasing the risk of pulmonary aspiration. Point-of-care gastric ultrasonography is a valid and feasible tool to assess gastric contents in diabetic and obese patients highlighting the need for anesthetists to become proficient in this skill.This is emphasized by the gap in the literature that exists regarding the appropriate amount of time in which GLP-1RAs should be held prior toelective surgery. Learning outcomes for the nurse anesthetist include understanding the current recommendations regarding preoperative management of GLP-1RAs and understanding the appropriate utilization of gastric ultrasonography when the gastric contents of a patient is inquestion.

1. Discuss the current evidence-based recommendations regarding preoperative management of patients taking GLP-1RAs.
2. Discuss the pillars of utility of point-of-care gastric ultrasound in patients whose gastric contents are in question.

This program has been prior approved by the American Association of Nurse Anesthesiology for 1.0 Class A CE credits; Code Number 1044811; Expiration Date 2/20/2025.  AANA designates this program as meeting the criteria for up to 1.0 CE Credits in pharmacology/therapeutics. 

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.